Literature DB >> 12503246

[Kennedy syndrome--bulbo-spinal muscular atrophy].

Antal Szabó1, Ferenc Mechler.   

Abstract

Kennedy syndrome is a late-onset, bulbar-spinal type of muscular atrophy, with X-linked recessive inheritance. The characteristic features of the disease become prominent in the 4-5th decades: proximal muscle wasting and weakness, bulbar signs, fasciculations in skeletal muscles, subtle signs of endocrine dysfunction, such as gynaecomastia or testicular atrophy. The electrophysiological examinations are the keypoint to the diagnosis. Electroneurography shows normal conduction velocity in peripheral nerves, but the sensory nerves usually show axonal degeneration, which causes only very mild or subclinical neurological deficits. Electromyography shows chronic anterior horn cell degeneration in skeletal muscles. Molecular genetic diagnosis was introduced in 1991, when on abnormal expansion of CAG repeat was found in the first exon of the androgen receptor gene on chromosome X with a frequency of 100% in the affected population. Since the progression is very slow and these patients can expect a normal life span, it is essential to distinguish this syndrome from other, often more severe diseases, such as ALS. There is no proven therapy for Kennedy's disease yet. This is the first case of Kennedy's disease published in Hungary.

Entities:  

Mesh:

Year:  2002        PMID: 12503246

Source DB:  PubMed          Journal:  Ideggyogy Sz        ISSN: 0019-1442            Impact factor:   0.427


  3 in total

1.  Rare association of antisynthetase syndrome and Kennedy's disease.

Authors:  Nora Szabo; Szilveszter Lukacs; Wiranthi Gunasekera; Katalin Danko
Journal:  Clin Rheumatol       Date:  2008-07-01       Impact factor: 2.980

2.  Only some patients with bulbar and spinal muscular atrophy may develop cardiac disease.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Mol Genet Metab Rep       Date:  2017-12-21

3.  Only some patients with bulbar and spinal muscular atrophy may develop cardiac disease.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Mol Genet Metab Rep       Date:  2017-11-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.